Literature DB >> 11886820

Mapping of possible binding sequences of two beta-sheet breaker peptides on beta amyloid peptide of Alzheimer's disease.

Csaba Hetényi1, Tamás Körtvélyesi, Botond Penke.   

Abstract

Aggregation of amyloid peptide (Abeta) has been identified as a major feature of the pathogenesis of Alzheimer's disease. Increased risk for disease is associated with increased formation of polymerized Abeta. Inhibition of formation of toxic (aggregated) form of Abeta is one of the therapeutic possibilities. Beta sheet breaker peptides (BSBs) fulfill the requirements of an effective inhibitor. After having attached to the Abeta molecules, BSBs can prevent aggregation of Abeta to polymeric forms (aggregates). In the present study, we performed molecular modelling of complex formation between Abeta and two BSB peptides. Our aim was to find proper binding sequences for the BSB peptides on Abeta and characterize them. A dimeric model of Abeta was also used to study the interaction of BSBs with the aggregated forms of Abeta and find the sequences responsible for the polymerization process. A fast and efficient computational method: molecular docking was used for the afore-mentioned purposes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11886820     DOI: 10.1016/s0968-0896(01)00424-2

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Efficient docking of peptides to proteins without prior knowledge of the binding site.

Authors:  Csaba Hetényi; David van der Spoel
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

2.  Hsp20, a novel alpha-crystallin, prevents Abeta fibril formation and toxicity.

Authors:  Sungmun Lee; Kenneth Carson; Allison Rice-Ficht; Theresa Good
Journal:  Protein Sci       Date:  2005-03       Impact factor: 6.725

3.  Chemical probes that selectively recognize the earliest Aβ oligomers in complex mixtures.

Authors:  Ashley A Reinke; Peter M U Ung; Jerome J Quintero; Heather A Carlson; Jason E Gestwicki
Journal:  J Am Chem Soc       Date:  2010-11-24       Impact factor: 15.419

4.  Reversal of temperature-induced conformational changes in the amyloid-beta peptide, Abeta40, by the beta-sheet breaker peptides 16-23 and 17-24.

Authors:  Funda F Bölükbaşi Hatip; Midori Suenaga; Tatsuo Yamada; Yoichi Matsunaga
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

5.  The Alzheimer beta-amyloid (Abeta(1-39)) dimer in an implicit solvent.

Authors:  Priya Anand; Fateh S Nandel; Ulrich H E Hansmann
Journal:  J Chem Phys       Date:  2008-11-21       Impact factor: 3.488

6.  Beta amyloid peptide: from different aggregation forms to the activation of different biochemical pathways.

Authors:  Marta Di Carlo
Journal:  Eur Biophys J       Date:  2009-03-21       Impact factor: 1.733

7.  Anti-amyloid aggregation activity of novel carotenoids: implications for Alzheimer's drug discovery.

Authors:  Johant Lakey-Beitia; Deborah Doens; D Jagadeesh Kumar; Enrique Murillo; Patricia L Fernandez; K S Rao; Armando A Durant-Archibold
Journal:  Clin Interv Aging       Date:  2017-05-15       Impact factor: 4.458

8.  Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis.

Authors:  Johant Lakey-Beitia; Jagadeesh Kumar D; Muralidhar L Hegde; K S Rao
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.